{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T07:05:32Z","timestamp":1771743932076,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Urology and Nephrology"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1007\/bf02550142","type":"journal-article","created":{"date-parts":[[2007,1,5]],"date-time":"2007-01-05T11:23:54Z","timestamp":1167996234000},"page":"79-85","source":"Crossref","is-referenced-by-count":11,"title":["Etoposide, epirubicin and carboplatin in hormone-refractory prostate cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"H.","family":"Fuse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Muraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02550142_CR1","first-page":"115","volume":"60","author":"R. Eagan","year":"1976","unstructured":"Eagan, R., Hahn, R., Myers, R.: Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.Cancer Treat. Rep., 60, 115 (1976).","journal-title":"Cancer Treat. Rep."},{"key":"BF02550142_CR2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000473570","volume":"19","author":"I. Elomaa","year":"1991","unstructured":"Elomaa, I., Kellokumpu-Lehtinen, P., Rannikko, S., Alfthan, O.: Hormone-resistant metastatic prostate cancer. Comparisons between estramustine phosphate and lowdose epirubicin treatments.Eur. Urol., 19, 12 (1991).","journal-title":"Eur. Urol."},{"key":"BF02550142_CR3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1464-410X.1971.tb10036.x","volume":"43","author":"J. F. Fergusson","year":"1971","unstructured":"Fergusson, J. F., Hendry, W. F.: Pituitary irradiation in advanced carcinoma of the prostate: Analysis of 100 cases.Br. J. Urol., 43, 514 (1971).","journal-title":"Br. J. Urol."},{"key":"BF02550142_CR4","first-page":"293","volume":"1","author":"C. Huggins","year":"1941","unstructured":"Huggins, C., Hodges, C. V.: Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.Cancer Res., 1, 293 (1941).","journal-title":"Cancer Res."},{"key":"BF02550142_CR5","volume-title":"General Rules for Clinical and Pathological Studies on Prostatic Cancer","author":"Japanese Urological Association & Japanese Pathological Society","year":"1985","unstructured":"Japanese Urological Association & Japanese Pathological Society: General Rules for Clinical and Pathological Studies on Prostatic Cancer. Kanehara, Tokyo 1985."},{"key":"BF02550142_CR6","first-page":"317","volume":"61","author":"D. E. Johnson","year":"1977","unstructured":"Johnson, D. E., Scott, W. W., Gibbons, R. P., Prout, G. R., Schmidt, J. D., Chu, T. M., Gaeta, J., Saroff, J., Murphy, G. P.: National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: A progress report.Cancer Treat. Rep., 61, 317 (1977).","journal-title":"Cancer Treat. Rep."},{"key":"BF02550142_CR7","first-page":"1317","volume":"71","author":"W. G. Jones","year":"1987","unstructured":"Jones, W. G., Foss\u00e5, S. D., Bono, A. V., Klijn, J. G. M., De Pauw, M., Sylvester, R.: European Organization for Research and Treatment of Cancer (EORTC) phase II study of low-dose weekly epirubicin in metastatic prostate cancer.Cancer Treat. Rep., 71, 1317 (1987).","journal-title":"Cancer Treat. Rep."},{"key":"BF02550142_CR8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJM197904123001504","volume":"300","author":"L. A. Klein","year":"1979","unstructured":"Klein, L. A.: Prostatic carcinoma.N. Engl. J. Med., 300, 824 (1979).","journal-title":"N. Engl. J. Med."},{"key":"BF02550142_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000473393","volume":"15","author":"M. Kontturi","year":"1988","unstructured":"Kontturi, M., Sotarauta, M., Tammela, T., Lukkarinen, O., Romppainen, M.-L., Gr\u00f6hn, P.: Sequentially alternating hormone chemotherapy with high-dose medroxy-progesterone acetate and low-dose epirubicin for the treatment of hormone-resistant metastatic prostatic cancer.Eur. Urol., 15, 43 (1988).","journal-title":"Eur. Urol."},{"key":"BF02550142_CR10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0090-4295(77)90035-8","volume":"10","author":"H. Lerner","year":"1977","unstructured":"Lerner, H., Malloy, T.: Hydroxyurea in stage D carcinoma of prostate.Urology, 10, 35 (1977).","journal-title":"Urology"},{"key":"BF02550142_CR11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0090-4295(79)90418-7","volume":"13","author":"C. Merrin","year":"1979","unstructured":"Merrin, C., Beckely, S.: Treatment of estrogen-resistant stage D carcinoma of the prostate with cis diamminedichloroplatinum.Urology, 13, 267 (1979).","journal-title":"Urology"},{"key":"BF02550142_CR12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00253058","volume":"18","author":"H. I. Scher","year":"1986","unstructured":"Scher, H. I., Sternberg, C. N., Heston, W. D. W., Watson, R. C., Niedzwiecki, D., Smart, T., Hollander, P., Yagoda, A.: The Community Cancer Oncology Program Investigators: Etoposide in prostatic cancer: Experimental studies and phase II trial in patients with bidimensionally measurable disease.Cancer Chemother. Pharmacol., 18, 24 (1986).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BF02550142_CR13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/0090-4295(76)90085-6","volume":"7","author":"J. D. Schmidt","year":"1976","unstructured":"Schmidt, J. D., Johnson, D. E., Scott, W. W., Gibbons, R. P., Prout, G. R., Murphy, G. P.: The National Prostatic Cancer Project: Chemotherapy of advanced prostatic cancer.Urology, 7, 602 (1976).","journal-title":"Urology"},{"key":"BF02550142_CR14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-5347(17)67172-6","volume":"114","author":"W. W. Scott","year":"1975","unstructured":"Scott, W. W., Johnson, D. E., Schmidt, J. E., Gibbons, R. P., Prout, G. R., Joiner, J. R., Saroff, J., Murphy, G. P.: Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: Results of first national randomized study.J. Urol. 114, 909 (1975).","journal-title":"J. Urol."},{"key":"BF02550142_CR15","first-page":"1589","volume":"61","author":"F. Tejda","year":"1977","unstructured":"Tejda, F., Eisenberger, M., Broder, L., Cohen, M., Simon, R.: 5-Fluorouracil versus CCNU in the treatment of metastatic prostatic cancer.Cancer Treat. Rep., 61, 1589 (1977).","journal-title":"Cancer Treat. Rep."},{"key":"BF02550142_CR16","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-92-5-681","volume":"92","author":"F. M. Torti","year":"1980","unstructured":"Torti, F. M., Carter, S. K.: The chemotherapy of prostatic adenocarcinoma.Ann. Intern. Med., 92, 681 (1980).","journal-title":"Ann. Intern. Med."},{"key":"BF02550142_CR17","first-page":"1195","volume":"68","author":"D. L. Trump","year":"1984","unstructured":"Trump, D. L., Loprinzi, C. L.: Phase II trial of etoposide in advanced prostate cancer.Cancer Treat. Rep., 68, 1195 (1984).","journal-title":"Cancer Treat. Rep."},{"issue":"Suppl.","key":"BF02550142_CR18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00171992","volume":"8","author":"D. L. Trump","year":"1990","unstructured":"Trump, D. L., Marsh, J. C., Kvols, L. K., Citrin, D., Davis, T. E., Hahn, R. G., Vogl, S. E.: A phase II trial of carboplatin (NSC 241240) in advanced prostate cancer, refractory to hormonal therapy. An Eastern Cooperative Oncology Group pilot study.Invest. New Drugs, 8 (Suppl.), 91 (1990).","journal-title":"Invest. New Drugs"},{"key":"BF02550142_CR19","first-page":"771","volume":"70","author":"P. J. Walther","year":"1986","unstructured":"Walther, P. J., Williams, S. D., Troner, M., Greco, F. A., Birch, R., Einhorn, L. H.: The Southeastern Cancer Study Group.Cancer Treat. Rep., 70, 771 (1986).","journal-title":"Cancer Treat. Rep."},{"key":"BF02550142_CR20","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1989.7.9.1318","volume":"7","author":"H. Wilke","year":"1989","unstructured":"Wilke, H., Preusser, P., Fink, U., Gunzer, U., Meyer, H.-J., Meyer, J., Siewert, J. R., Achterrath, W., Lenaz, L., Knipp, H., Schmoll, H. J.: Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: A phase II study with etoposide, doxorubicin, and cisplatin.J. Clin. Oncol., 7, 1318 (1989).","journal-title":"J. Clin. Oncol."},{"key":"BF02550142_CR21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1002\/1097-0142(19930201)71:3+<1098::AID-CNCR2820711432>3.0.CO;2-G","volume":"71","author":"A. Yagoda","year":"1993","unstructured":"Yagoda, A., Petrylak, D.: Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer.Cancer, 71, 1098 (1993).","journal-title":"Cancer"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02550142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02550142\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02550142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T21:28:35Z","timestamp":1707514115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02550142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["BF02550142"],"URL":"https:\/\/doi.org\/10.1007\/bf02550142","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1]]}}}